Pulnovo Medical

CompanyChina

Pulnovo Medical develops 2 assets, the furthest in human trials (Enhancor System in cardiovascular disease). Mostly device; based in China.

2
Assets
Furthest stage
Human trials
1
Trial
0
Signals

Pipeline

2
  • Enhancor System

    Multi-pole radiofrequency catheter ablation system for pulmonary artery denervation.

    Human trials, Device, cardiovascular disease, heart failure

  • The Enhancor System

    Radiofrequency catheter ablation system for pulmonary artery denervation

    Human trials, Device, cardiovascular disease, heart failure

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Signals1
  • Similar companies6

Intelligence